Usefulness of urine dipstick test in the management of adverse events associated with immune checkpoint inhibitors

被引:0
|
作者
Izumi, Keishiro [1 ]
Iyoda, Tomokazu [1 ,2 ]
Yokota, Atsuko [3 ]
Kanno, Masahito [2 ]
Hoshi, Masahiro [2 ]
Tokuda, Emi [4 ]
Sasaki, Eisaku [4 ]
Kanazawa, Kenya [1 ]
Kuroda, Junko [2 ]
Saji, Shigehira [1 ,4 ]
机构
[1] Fukushima Med Univ Hosp, Clin Oncol Ctr, 1 Hikarigaoka, Fukushima, Fukushima, Japan
[2] Fukushima Med Univ Hosp, Dept Pharm, 1 Hikarigaoka, Fukushima, Fukushima, Japan
[3] Tochigi Canc Ctr, Dept Pharm, 4-9-13 Yonan, Utsunomiya, Tochigi, Japan
[4] Fukushima Med Univ, Dept Med Oncol, 1 Hikarigaoka, Fukushima, Fukushima, Japan
关键词
Immune checkpoint inhibitor; Urine dipstick test; Patient's diary; Telephone follow-up; Pharmacist; THERAPY MANAGEMENT; URINALYSIS; DIARY;
D O I
10.1007/s00520-024-08928-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PurposeThe usefulness of urine dipstick tests (UDTs) in patients with diabetes has been reported. The aim of the present study was to investigate the utility of self-performed UDTs and patient diaries in the management of impaired glucose tolerance, one of the adverse events of immune checkpoint inhibitors (ICIs).MethodsPatients receiving ICIs underwent self-checks with UDTs twice a week for up to 6 months. Pharmacists checked the results at every patient visit, and by phone every 3 months. The primary endpoint was to prospectively assess whether symptoms recorded in patient diaries and UDTs could reduce unscheduled hospital admissions due to impaired glucose tolerance. The secondary endpoint was the correlation between the symptoms in the patient diaries and UDT results.ResultsA total of 112 patients were enrolled in the study. Out of the 3197 planned self-UDTs, 3128 (97.8%) were performed. Forty-four patients (39.3%) were admitted to the hospital, two (1.8%) of whom were admitted due to abnormal glucose tolerance, with one having a positive UDT. There were 46 unscheduled outpatient visits (41.1%), of which five (4.5%) were due to abnormal glucose tolerance symptoms and four were due to a positive UDT. The correlation between descriptions of fatigue or dry mouth in the patient diaries and positive glucose UDTs was 52.4% in sensitivity and 62.4% in specificity.ConclusionSelf-monitoring of symptoms and self-performing of UDTs could not reduce the emergency hospitalization rate. However, this approach could be effective in the objective monitoring of patient status, especially regarding glucose intolerance occurrences.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Usefulness of urine dipstick test in the management of adverse events associated with immune checkpoint inhibitors
    Izumi, Keishiro
    Iyoda, Tomokazu
    Yokota, Atsuko
    Higuchi, Kazue
    Sasaki, Eisaku
    Saji, Shigehira
    ANNALS OF ONCOLOGY, 2023, 34 : S1424 - S1424
  • [2] Adverse Events Associated With Immune Checkpoint Inhibitors
    Akturk, Halis Kaan
    Michels, Aaron W.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (12): : 1219 - 1219
  • [3] Neurological Adverse Events Associated with Immune Checkpoint Inhibitors: Diagnosis and Management
    Astaras, Christophoros
    de Micheli, Rita
    Moura, Bianca
    Hundsberger, Thomas
    Hottinger, Andreas F.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2018, 18 (01)
  • [4] Neurological Adverse Events Associated with Immune Checkpoint Inhibitors: Diagnosis and Management
    Christophoros Astaras
    Rita de Micheli
    Bianca Moura
    Thomas Hundsberger
    Andreas F. Hottinger
    Current Neurology and Neuroscience Reports, 2018, 18
  • [5] Cutaneous adverse events associated with immune checkpoint inhibitors
    Graen, Franziska
    Schilling, Bastian
    AKTUELLE DERMATOLOGIE, 2023, 49 (11) : 517 - 524
  • [6] Cutaneous Adverse Events Associated with Immune Checkpoint Inhibitors
    Graen, Franziska
    Schilling, Bastian
    AKTUELLE RHEUMATOLOGIE, 2022, 47 (04) : 344 - 352
  • [7] Biomarkers for adverse events associated with immune checkpoint inhibitors
    Kourie, Hampig Raphael
    Paesmans, Marianne
    Klastersky, Jean
    BIOMARKERS IN MEDICINE, 2016, 10 (10) : 1029 - 1031
  • [8] Management of challenging immune-related gastrointestinal adverse events associated with immune checkpoint inhibitors
    Hamamoto, Yasuo
    Shin, Natalya
    Hoshino, Tomohiro
    Kanai, Takanori
    FUTURE ONCOLOGY, 2018, 14 (30) : 3187 - 3198
  • [9] Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors
    Day, Daphne
    Hansen, Aaron R.
    BIODRUGS, 2016, 30 (06) : 571 - 584
  • [10] Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors
    Daphne Day
    Aaron R. Hansen
    BioDrugs, 2016, 30 : 571 - 584